{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:15:29Z","timestamp":1787508929669,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cyto.2024.156555","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T01:37:06Z","timestamp":1708565826000},"page":"156555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Interferon-\u03b1 induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion"],"prefix":"10.1016","volume":"177","author":[{"given":"Yu-Ting","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Song","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cyto.2024.156555_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"15","key":"10.1016\/j.cyto.2024.156555_b0010","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156555_b0015","unstructured":"Global Burden of Disease Liver Cancer Collaboration; Akinyemiju T, Abera S, et al., The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015, JAMA Oncol. 3 (12) (2017) 1683-1691."},{"issue":"6","key":"10.1016\/j.cyto.2024.156555_b0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2015.02.038","article-title":"The yin and yang of evasion and immune activation in HCC","volume":"62","author":"Makarova-Rusher","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156555_b0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/17512433.2019.1598859","article-title":"Novel immunotherapeutic approaches for hepatocellular carcinoma treatment","volume":"12","author":"Busato","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156555_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cyto.2024.156555_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2019.03.012","article-title":"Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines","volume":"119","author":"Peng","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156555_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107692","article-title":"Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression","volume":"219","author":"Fousek","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cyto.2024.156555_b0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-020-0856-x","article-title":"Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors","volume":"26","author":"Schalper","year":"2020","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156555_b0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41591-020-0860-1","article-title":"High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade","volume":"26","author":"Yuen","year":"2020","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cyto.2024.156555_b0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","article-title":"Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1245\/s10434-021-10269-7","article-title":"Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2\/5 Inhibitor or an Anti-IL-8 Antibody","volume":"29","author":"Rossi","year":"2022","journal-title":"Ann. Surg. Oncol."},{"issue":"10161","key":"10.1016\/j.cyto.2024.156555_b0065","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","article-title":"Chronic hepatitis B virus infection","volume":"392","author":"Seto","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cyto.2024.156555_b0070","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/0008-5472.CAN-08-2831","article-title":"IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53","volume":"69","author":"Herzer","year":"2009","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cyto.2024.156555_b0075","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.onc.1200939","article-title":"IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells","volume":"14","author":"Hobeika","year":"1997","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0080","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1038\/s41467-018-06890-y","article-title":"Targeting IFN\u03b1 to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance","volume":"9","author":"Liang","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cyto.2024.156555_b0085","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/2159-8290.CD-21-1022","article-title":"IFN\u03b1 Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment","volume":"12","author":"Hu","year":"2022","journal-title":"Cancer Discov."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156555_b0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.virol.2013.06.028","article-title":"Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha","volume":"444","author":"Pollicino","year":"2013","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.cyto.2024.156555_b0095","doi-asserted-by":"crossref","first-page":"21286","DOI":"10.3390\/ijms151121286","article-title":"Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy","volume":"15","author":"Yang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2024.156555_b0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10517-016-3393-3","article-title":"IFN-\u03b1, IFN-\u03b2, and IFN-\u03b3 Have Different Effect on the Production of Proinflammatory Factors Deposited in Weibel-Palade Bodies of Endothelial Cells Infected with Herpes Simplex Virus Type 1","volume":"161","author":"Shcheglovitova","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"issue":"11","key":"10.1016\/j.cyto.2024.156555_b0105","doi-asserted-by":"crossref","first-page":"e204564","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156555_b0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1470-2045(20)30011-5","article-title":"Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial","volume":"21","author":"Qin","year":"2020","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e3182363ff9","article-title":"Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection","volume":"255","author":"Chen","year":"2012","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3816\/CGC.2008.n.004","article-title":"Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma","volume":"6","author":"Feldman","year":"2008","journal-title":"Clin. Genitourin. Cancer"},{"issue":"10","key":"10.1016\/j.cyto.2024.156555_b0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5483\/BMBRep.2020.53.10.149","article-title":"A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity","volume":"53","author":"Kim","year":"2020","journal-title":"BMB Rep."},{"issue":"22","key":"10.1016\/j.cyto.2024.156555_b0130","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.1074\/jbc.M113.544320","article-title":"Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia","volume":"289","author":"Waight","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cyto.2024.156555_b0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminoncol.2014.02.002","article-title":"Interferons and their stimulated genes in the tumor microenvironment","volume":"41","author":"Cheon","year":"2014","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0140","doi-asserted-by":"crossref","first-page":"e000308","DOI":"10.1136\/jitc-2019-000308","article-title":"Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cyto.2024.156555_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155828","article-title":"Interleukin-8: An evolving chemokine","volume":"153","author":"Matsushima","year":"2022","journal-title":"Cytokine"},{"issue":"15","key":"10.1016\/j.cyto.2024.156555_b0150","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-15-2463","article-title":"Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)","volume":"22","author":"Alfaro","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","article-title":"Drug resistance and Cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal"},{"issue":"4","key":"10.1016\/j.cyto.2024.156555_b0160","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.cyto.2024.156555_b0165","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1089\/scd.2015.0202","article-title":"CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem\/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates","volume":"24","author":"Zeng","year":"2015","journal-title":"Stem Cells Dev."},{"issue":"8","key":"10.1016\/j.cyto.2024.156555_b0170","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1742-1241.2008.01777.x","article-title":"Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma","volume":"62","author":"Song","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.cyto.2024.156555_b0175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12885-017-3460-9","article-title":"The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.cyto.2024.156555_b0180","first-page":"2092","article-title":"Nuclear CD133 expression predicts poor prognosis for hepatocellular carcinoma","volume":"11","author":"Yu","year":"2018","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"4","key":"10.1016\/j.cyto.2024.156555_b0185","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.27968","article-title":"Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma","volume":"62","author":"Won","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2024.156555_b0190","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.2147\/OTT.S262089","article-title":"IL-6\/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells","volume":"13","author":"Li","year":"2020","journal-title":"Onco Targets Ther."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:49:20Z","timestamp":1760910560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"alternative-id":["S1043466624000589"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156555","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b1 induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156555"}}